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Background: Valid instrumentation in the assessment of health-related quality of life (HQoL) in 
renal transplant recipients is critical to identifying particular nuances and determinants of HQoL 
in this population. Therefore, the validity of disease-specific instruments to measure HQoL in 
renal transplant recipients, such as the Kidney Transplant Questionnaire (KTQ), needs further 
investigation. The objective of this study was to assess the concurrent validity of the KTQ in 
adult US renal transplant recipients using the well established SF-12 Health Survey version 2 
(SF-12v2) as the comparison instrument.
Methods: One hundred and fourteen renal transplant recipients met the following inclusion 
criteria for this study, ie, were at least 21 years of age, more than two years post-transplant, 
and receiving immunosuppressant therapy. Subjects were asked to complete a series of HQoL 
instruments, ie, the KTQ and the SF-12v2 (physical component summary [PCS-12] and men-
tal component summary [MCS-12]). Descriptive statistics were calculated, and correlational 
analyses were conducted to examine the concurrent validity of the HQoL instruments.
Results: Among 100 participants (87.7% response rate), the majority of participants were male 
(52%), had deceased donor transplants (63%), and received Medicare benefits (84%). PCS-12 was 
positively correlated with three of five KTQ subscales (P , 0.05), ie, KTQ-physical (r = 0.43), 
KTQ-fatigue (r = 0.42), and KTQ-uncertainty/fear (r = 0.2). MCS-12 was positively correlated 
with all KTQ subscales (P , 0.01), ie, KTQ-physical (r = 0.26), KTQ-fatigue (r = 0.48), KTQ-
uncertainty/fear (r = 0.33), KTQ-emotional (r = 0.47), and KTQ-appearance (r = 0.28).
Conclusion: The findings support the concurrent validity of the KTQ in US renal transplant 
recipients. Future studies should continue exploring the validity of the KTQ, as well as its 
practical and research utility in HQoL measurement in the renal transplant population.
Keywords: concurrent validity, kidney transplant questionnaire, quality of life, renal transplant 
recipients, SF-12 Health Survey
Introduction
The purpose of renal transplant is not simply to extend life and improve health out-
comes, but to enhance quality of life. Health-related quality of life (HQoL) is defined 
by the World Health Organization as “... individuals’ perception of their position in 
life in the context of the culture and value systems in which they live and in relation 
to their goals, expectations, standards, and concerns”.1 HQoL is an important outcome 
measure in the renal transplant field, and its spectrum includes physical, psychological, 
social, and general well-being. Rebollo et al2 described the necessity of examining 
HQoL in transplant and other patient populations as follows to:
•	 Evaluate efficacy of medical interventions
•	 Improve the clinical decision-making process
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•	 Assess quality of care
•	 Estimate patient population’s health care needs
•	 Better understand causes and consequences of health 
differences within a patient population
Research demonstrates that HQoL tends to improve after 
undergoing renal transplant as compared with remaining 
on dialysis.3–5 However, HQoL changes in renal transplant 
recipients are variable, and may be influenced by clinical, 
social, demographic, and environmental factors.4 Because 
of this noted variation, valid, reliable, and well constructed 
instrumentation in the assessment of HQoL is critical to 
identifying particular nuances or determinants of HQoL in 
renal transplant recipients. To that end, a small number of 
HQoL instruments specific to renal transplantation have been 
developed. These disease-specific instruments tend to focus 
on those symptoms, effects, and issues that are commonly 
associated with renal transplantation. One such instrument is 
the Kidney Transplant Questionnaire (KTQ), developed by 
Laupacis et al, which assesses characteristics and conditions 
associated with life post-transplant.6 Although previous stud-
ies provide evidence of the validity of the KTQ in non-US 
renal transplant populations, a literature search (PubMed, 
years unlimited) revealed little to no evidence regarding 
the validity of the instrument among US renal transplant 
recipients.2,6,7 Because there are few HQoL instruments avail-
able specific to the renal transplant population, it is important 
to develop support for the validity of existing measures such 
as the KTQ. Access to valid, disease-specific HQoL mea-
sures may allow for more complete comprehension of the 
quality of life-related benefits (ie, improvements in HQoL in 
certain domains) and limits (ie, circumstances under which 
HQoL does not improve or improves only minimally) of 
transplant as a medical intervention in US renal transplant 
recipients. Therefore, the objective of this study was to 
assess the concurrent validity (defined as evaluation of an 
instrument against an already validated measure or criterion 
of the construct the instrument should be assessing8–10) of the 
KTQ in adult US renal transplant recipients using the well 
established SF-12 Health Survey version 2 (SF-12v2) as the 
comparison instrument.
Materials and methods
One hundred and fourteen renal transplant recipients 
met the following enrollment criteria for this cross-
sectional survey (note that recruitment of renal transplant 
recipients, and therefore inclusion criteria, was part of 
a larger, ongoing randomized controlled trial conducted 
by Chisholm-Burns et al) and were: at least 21 years of 
age; more than two years post-transplant; and receiving 
  immunosuppressant therapy from the Apothecary Shops 
(a chain of pharmacies based in the Southwest US). As 
part of enrollment into the randomized controlled trial, 
participants were asked to complete and return mailed 
surveys, which included a demographics questionnaire and 
the KTQ and SF-12v2 HQoL instruments. Renal transplant 
recipients who did not return the survey packet within two 
weeks received one follow-up telephone call reminder. This 
study was approved by the Institutional Review Board of 
The University of Arizona.
hQoL instrumentation
Kidney Transplant Questionnaire
The KTQ is a 25-item questionnaire that includes five 
domains or subscales, ie, physical symptoms (based on 
six items), fatigue (based on five items), uncertainty/fear 
(based on four items), appearance (based on four items), and 
emotional (based on six items).6 A mean score ranging from 
1 to 7 is reported for each of the five subscales, with higher 
scores representing better functioning, well-being, or fewer 
problems. Evidence supporting the validity and reliability 
(Cronbach’s alpha and intraclass coefficients of subscales 
range from 0.69 to 0.90) of the KTQ has been reported in 
non-US renal transplant recipients.2,6,7
SF-12 health Survey version 2
The SF-12v2, a well validated brief, generic HQoL ques-
tionnaire, is a shortened form of the SF-36 Health Survey 
(SF-36).11 The SF-36 is a commonly used HQoL measure 
in the renal transplant literature, and has been utilized to 
validate other disease-specific symptom and health status 
measures.3,12–14 Similar to the SF-36, the SF-12v2 assesses 
functional status, well-being, and perceptions of health 
status across eight domains, ie, physical functioning, role 
functioning-physical, bodily pain, general health, vitality, 
social functioning, role functioning-emotional, and men-
tal health. The scores from the eight domains are used to 
calculate a physical component summary (PCS-12) score 
and a mental component summary (MCS-12) score. Note, 
for studies such as ours in which sample sizes are relatively 
small (ie, ,500 participants), reporting of just the PCS-12 
and MCS-12 scores is appropriate; thus, we utilized only 
the PCS-12 and MCS-12 scores in our concurrent validity 
analysis.11 The domain scores derived from the SF-12v2 are 
based on fewer items and fewer defined levels of health than 
the SF-36 and, as a result, are estimated with less precision 
and less reliability. Despite these possible limitations, the 
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SF-12v2 was selected because its brevity is appealing in 
reducing burden on patients, particularly when administered 
in conjunction with a lengthier instrument such as the KTQ. 
Scores on the SF-12v2 are based on normative scaling 
and range from 0 to 100, with 50 considered the average 
functioning score. Higher PCS-12 and MCS-12 scores are 
indicative of better functioning and well-being. Across 
numerous patient populations, Cronbach’s alpha coeffi-
cients for the PCS-12 and MCS-12 greater than 0.70 have 
been reported, and evidence supporting the validity of the 
SF-12v2 has been found.11
hypotheses
The KTQ has not been validated using the SF-12v2, but 
Rebollo et al2 have previously validated the KTQ in Span-
ish renal transplant recipients using the SF-36, which has 
physical and mental component scores similar to those of 
the PCS-12 and MCS-12 of the SF-12v2.2 The following 
exploratory hypotheses are based on the correlational find-
ings of Rebollo et al:
•	 The PCS-12 will be positively correlated at the low to 
moderate level (r = 0.2–0.4) with the KTQ-physical, 
KTQ-fatigue, and KTQ-appearance subscales, and will 
be positively correlated at the low level (r = 0.1–0.2) with 
the KTQ-uncertainty/fear subscale.
•	 The MCS-12 will be positively correlated at the greater 
than moderate level (r . 0.4) with the KTQ-emotional, 
KTQ-uncertainty/fear, and KTQ-fatigue subscales, and 
will also be positively correlated at the low to moderate 
level (r = 0.2–0.4) with the KTQ-physical and KTQ-
appearance subscales.
Statistical analysis
To perform the statistical analyses, we used SPSS   version 
18/PASW Statistics 18 (SPSS Inc, Chicago, IL).   Descriptive 
statistics of demographic and HQoL variables were 
  calculated. To assess reliability, Cronbach’s alpha coef-
ficients were calculated for the HQoL instruments. Ceiling 
and floor effects for each scale were tested by running 
frequencies for each scale and documenting the percent-
age of respondents who scored at the top and bottom of 
each scale. Ceiling and floor effects less than 15% were 
considered minimal, while effects greater than 15% were 
considered moderate to substantial, according to criteria used 
by McHorney and Tarlov.15 To assess concurrent validity, 
analyses were conducted to examine Pearson’s r correlations 
among the PCS-12, MCS-12, and KTQ subscales. An alpha 
priori level of 0.05 was used.
Results
The response rate was 87.7% (100 of 114 renal   transplant 
recipients). The mean age of respondents was 51.0 ± 13.2 years 
and the mean months post-transplant was 39.7 ± 29.8 
(Table 1). The majority of participants were male (52%), 
had deceased donor transplants (63%), and received 
Medicare benefits (84%, Table 1). The mean scores on the 
HQoL instruments were as follows: PCS-12, 43.7 ± 11.6; 
MCS-12, 51.5 ± 10.6; KTQ-physical, 4.5 ± 1.5; KTQ-fatigue, 
5.4 ± 1.4; KTQ-uncertainty/fear, 5.4 ± 1.3; KTQ-appearance, 
6.8 ± 0.6; and KTQ-emotional, 5.4 ± 1.2. Cronbach’s alpha 
for each scale is presented in Table 2. Neither ceiling nor 
floor effects were noted for the PCS-12 or MCS-12. There 
were modest ceiling effects for KTQ-physical, KTQ-fatigue, 
KTQ-uncertainty/fear, and KTQ-emotional subscales, rang-
ing from 15% to 27% of respondents receiving the highest 
possible score. A substantial ceiling effect was present for 
the KTQ-appearance subscale, with 84% of renal transplant 
recipients receiving the highest possible score.
The correlation matrix is presented in Table 3. Generally, 
the following patterns of correlations between the HQoL 
Table 1 Demographic characteristics (n = 100)
Characteristic Frequency (%)
Mean age ± SD, years 51.0 ± 13.2
Gender
  Male
  Female
 
52 (52)
48 (48)
Education
  Less than high school
  high school graduate
  Some college/associate degree
  College graduate or higher
  Other
  Missing data
 
17 (17)
23 (23)
35 (35)
20 (20)
2 (2)
3 (3)
Employment status
  Employed
  Not employed
  Missing data
 
33 (33)
65 (65)
2 (2)
Marital status
  Not married
  Married
 
59 (59)
41 (41)
Race
  White
  Other
 
50 (50)
50 (50)
Received Medicare benefits
  No
  Yes
 
16 (16)
84 (84)
Type of transplant
  Living donor
  Deceased donor
 
37 (37)
63 (63)
Mean months post-transplant ± SD 39.7 ± 29.8
Abbreviation: SD, standard deviation.
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scores were confirmed. As hypothesized, the PCS-12 was 
positively correlated at the low level (r = 0.2; P , 0.05) with 
the KTQ-uncertainty/fear subscale. Correlations between the 
PCS-12 and the KTQ-physical and KTQ-fatigue subscales 
were slightly higher than hypothesized (r . 0.4; P , 0.001). 
Although hypothesized to be positively correlated at the low 
level, the PCS-12 and KTQ-appearance subscale were not 
significantly correlated (P . 0.05). Also as hypothesized, 
the MCS-12 was positively correlated at the greater than 
moderate level with the KTQ-emotional and KTQ-fatigue 
subscales (r . 0.4; P , 0.001), and was positively correlated 
at the low to moderate level with the KTQ-physical and 
KTQ-appearance subscales (r = 0.26 and 0.28, respectively; 
P , 0.01). Although hypothesized to be positively correlated 
at the greater than moderate level, the MCS-12 was correlated 
at the low to moderate level with the KTQ-uncertainty/fear 
subscale (r = 0.33; P , 0.01).
Discussion
As there are few instruments designed specifically to assess 
HQoL in the renal transplant population, comprehensive 
validity testing of existing measures such as the KTQ is 
needed across renal transplant populations. The current 
study is the first to examine the concurrent validity of the 
KTQ in a sample of US renal transplant recipients using the 
SF-12v2 as the comparison instrument. The findings of our 
study provide support for the reliability of both instruments. 
We found acceptable to good Cronbach’s alphas (.0.75) for 
five of seven scales (PCS-12, MCS-12, KTQ-physical, KTQ-
fatigue, and KTQ-emotional).16 The two remaining scales, the 
KTQ-appearance and KTQ-uncertainty/fear, had Cronbach’s 
alphas approaching acceptability (.0.6).16   Reliability coef-
ficients found in this study for each instrument are similar 
to those noted in previous studies.2,6,11,17
Study findings provide support for the concurrent validity 
of the KTQ in our sample, because the positive   correlations 
between the KTQ and SF-12v2 indicate that the scales 
hypothesized to measure similar concepts were, for the most 
part, significantly associated. In examining the relationship 
between the KTQ and SF-12v2, correlations which are clini-
cally and psychometrically sensible were found between the 
KTQ subscale scores and SF-12v2 component summary 
scores. To elaborate, the PCS-12 is most highly correlated 
with the KTQ-physical (r = 0.43) and KTQ-fatigue subscales 
(r = 0.42), while the MCS-12 is most highly correlated with 
the KTQ-emotional (r = 0.47) and KTQ-fatigue (r = 0.48) 
subscales. The findings regarding the fatigue subscale are 
particularly important given that the causes and effects of 
fatigue have both physical and mental elements. Our results 
offer the first body of evidence concerning the concurrent 
validity of the KTQ with the SF-12v2.
The findings regarding the relationships between the 
KTQ subscales and the SF-12v2 vary somewhat from 
those presented by Rebollo et al in their examination of 
the validity of the KTQ using the SF-36 in a sample of 
  Spanish renal transplant recipients.2 For example, Rebollo 
et al found that correlations between the KTQ subscales and 
the physical component summary of the SF-36 (PCS-36) 
were low (less than 0.3 for all KTQ subscales), while two 
of the correlations found between the PCS-12 and KTQ 
Table 2 Cronbach’s alpha for the health-related quality of life 
instruments
HQoL instrument Cronbach’s alpha
PCS-12 0.92
MCS-12 0.88
KTQ-physical 0.82
KTQ-fatigue 0.90
KTQ-uncertainty/fear 0.63
KTQ-appearance 0.62
KTQ-emotional 0.82
Abbreviations:  hQoL,  health-related  quality  of  life;  KTQ,  Kidney  Transplant 
Questionnaire; MCS-12, mental component summary of the SF-12 health survey; 
PCS-12, physical component summary of the SF-12 health survey.
Table 3 health-related quality of life instrument correlation matrix
Instrument PCS-12 MCS-12 KTQ- 
physical
KTQ- 
fatigue
KTQ- 
uncertainty/fear
KTQ- 
appearance
KTQ- 
emotional
PCS-12 – 0.112 0.43*** 0.42*** 0.20* -0.01 0.10
MCS-12 0.112 – 0.26** 0.48*** 0.33** 0.28** 0.47***
KTQ-physical 0.43*** 0.26** – 0.59*** 0.47*** 0.29** 0.52***
KTQ-fatigue 0.42*** 0.48*** 0.59*** – 0.54*** 0.31** 0.61***
KTQ-uncertainty/fear 0.20* 0.33** 0.47*** 0.54*** – 0.40*** 0.71***
KTQ-appearance -0.01 0.28** 0.29** 0.31** 0.40*** – 0.36***
KTQ-emotional 0.10 0.47*** 0.52*** 0.61*** 0.71*** 0.36*** –
Notes: *P , 0.05; **P , 0.01; ***P , 0.001.
Abbreviations: KTQ, Kidney Transplant Questionnaire; MCS-12, mental component summary of the SF-12 health survey; PCS-12, physical component summary of the 
SF-12 health survey.
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subscales in this study were greater than 0.4.2 Addition-
ally, although the correlations found in the current study 
using the MCS-12 were significant, Rebollo et al found 
correlations between the KTQ subscales and the mental 
component summary of the SF-36 (MCS-36) that were 
considerably higher than those found in our study.2 This is 
particularly noteworthy in the case of KTQ-uncertainty/fear. 
We speculate that differences in time post-transplant may 
be associated with the variations in results found between 
the current study and Rebollo et al. In the Rebollo et al 
study, validity was tested at six months post-transplant, 
whereas the average time post-transplant in the current 
study was greater than 39 months, a period of time in which 
patients are likely to adjust to their clinical post-transplant 
status, which in turn is likely to influence their HQoL.18 
Given that renal transplant recipients who are at least two 
years post-transplant are generally more clinically stable 
compared with renal transplant recipients within the first 
year post-transplant, we likewise believe our findings rep-
resent a more stable assessment of HQoL.
Like all studies, ours has limitations. The generalizabil-
ity of the results may be limited by the sample size of this 
study and the demographic makeup of the sample. Female 
and non-white renal transplant recipients are somewhat 
overrepresented compared with the general US transplant 
population: female renal transplant recipients, 48% of the 
sample versus 40% of the US population; and non-white 
renal transplant recipients, 50% of the sample versus 41% 
of the US population.19 Another limitation is the lack of 
an objective measure of renal function or other physi-
ological indicators of graft (transplanted kidney) function 
or   rejection. We were thus unable to stratify patients by 
disease severity to test the validity of the KTQ further. 
However, since all renal transplant recipients were tak-
ing immunosuppressant therapy according to pharmacy 
refill records, during the time of instrument completion 
we assume that all study participants had functioning 
grafts. Possible ceiling and floor effects were evaluated and 
determined to be minimal for the SF-12v2, but the KTQ 
subscales (particularly the KTQ-appearance) had moderate 
to substantial ceiling effects. The substantial (84%) ceiling 
effect indicated for the KTQ-appearance subscale may have 
contributed to the lack of significance associated with this 
measure and the PCS-12, but generally did not appear to 
influence the findings pertaining to other KTQ subscales. 
Despite these limitations, we believe the study results are 
indicative of good concurrent validity of the KTQ in our 
sample of US renal transplant recipients.
Conclusion
HQoL is an important outcome in the renal transplant popu-
lation, and valid and reliable transplant-specific instruments 
are needed to conduct comprehensive assessment of HQoL. 
Thus, we examined and found considerable support for the 
concurrent validity of the KTQ, a HQoL instrument specific 
to renal transplantation in US renal transplant recipients. 
Future studies should continue exploring the validity of the 
KTQ, as well as its practical and research utility in HQoL 
measurement in the renal transplant population.
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